Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tetra-aryl cyclobutane inhibitors of androgen receptor action for the treatment of hormone refractory cancer

Tetra-aryl cyclobutane inhibitors of androgen receptor action for the treatment of hormone refractory cancer

US Patent 9868705 · Granted Jan 16, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lasofoxifene treatment of breast cancer2025
Estrogen receptor beta ligands for the prevention and treatment of multiple scle2025
Method of treating cancer using selective estrogen receptor modulators2025
FOXM1 inhibitor compositions and methods of using the same2025
CaMKK2 inhibitor compositions and methods of using the same2024
Lasofoxifene treatment of breast cancer2024
Lasofoxifene treatment of breast cancer2024
Method of treating cancer using selective estrogen receptor modulators2024
Method of treating cancer using selective estrogen receptor modulators2023
Estrogen receptor beta ligands for the prevention and treatment of multiple scle2023
Antiestrogen compounds2023
Lasofoxifene treatment of breast cancer2022